Professional Education and Training Roster
*Members of the IPRCC
#Members of the NPS Oversight Panel
†Served on the IOM Conference on Pain
Rollin M. Gallagher, MD, MPH is Deputy National Program Director for Pain Management, Veterans Health Administration (VHA) and Co-chair of the Pain Management Workgroup, DoD-VA Health Executive Council at the Philadelphia Veteran Affairs Medical Center where he is also Clinical Professor of Psychiatry and of Anesthesiology and Director for Pain Policy Research and Primary Care at Penn Pain Medicine, University of Pennsylvania School of Medicine, and Editor-in-Chief, Pain Medicine, He received a BA from Harvard, MD from Boston University and after family practice experience in Colorado and psychiatry residency at Dartmouth, he held a joint appointment in psychiatry and family practice where he directed an NIMH-funded program teaching biopsychosocial medicine to primary care and students an d an interdisciplinary behavioral medicine service and pain clinic at the University of Vermont (1982-1989), also serving as a residency director and asst. dean for graduate medical education. Following a mid-career NIH post-doctoral epidemiology fellowship studying pain and depression and MPH at Columbia, he founded and directed the Comprehensive Pain and Rehabilitation Center at SUNY Stony Brook in New York (1990-1997) before moving to Drexel and then to Penn. Besides a career-long role in teaching biopsychosocial medicine focused on pain to multiple specialties, disciplines and patients, he has served in several national organizations dedicated to pain education, research and policy, with leadership positions such as President of the American Board of Pain Medicine (2002-4), President of the American Academy of Pain Medicine (2009-10), and membership on the Pain Examination Committee of the American Board of Anesthesia and the Committee on Pain Medicine Fellowships of the American Council on Graduate Medical Education. Since joining the VHA in 2004, he has served in various roles working closely on pain research, education and policy with the Department of Defense, including the Army Pain Management Task Force and the VHA’s National Pain Management Strategy Coordinating Committee. He is presently involved in studies of battlefield injuries, opioid analgesic use in primary care, the development of an interactive clinical assessment tool and data registry (PASTOR-PROMIS), and implementation of health policy in pain management. He lectures nationally and internationally and publishes extensively on topics related to pain. Dr. Gallagher co-chairs the Professional Education and Training working group with Dr. James Rathmell.
Dr. Rathmell is Professor of Anaesthesia at Harvard Medical School and Executive Vice Chair and Chief of the Division of Pain Medicine at Massachusetts General Hospital. He devotes his time to his clinical practice, research, and education. Dr. Rathmell’s research work has included a mixture of investigator-initiated and industry-sponsored trials examining the effectiveness of new and emerging treatments for pain. He lectures widely in the U.S. and internationally, and has delivered several hundred lectures to students, medical professionals, and members of the public. Dr. Rathmell currently serves as Director of the American Board of Anesthesiologists, Vice Chair of the Anesthesiology RRC Division of the ACGME, and Associate Editor of Anesthesiology. He has published widely, including his most recent textbook: Atlas of Image-Guided Intervention in Regional Anesthesia and Pain Medicine, 2nd Edition. Dr. Rathmell co-chairs the Professional Education and Training working group with Dr. Rollin (Mac) Gallagher.
Dr. Berman, professor, Family and Community Medicine; director, Center for Integrative Medicine University of Maryland School of Medicine, is recognized as a pioneer in the field of integrative medicine. Twenty-two years ago, he founded the Center for Integrative Medicine that was the first program of its kind at a U.S. academic health center. A National Institutes of Health-funded researcher, he has published extensively on acupuncture and mind/body medicine in such prestigious journals as the Annals of Internal Medicine and the New England Journal of Medicine. He served as the first chair of the Consortium of Academic Health Centers for Integrative Medicine, which now includes 55 member institutions. Additionally, Dr. Berman co-founded the complementary medicine field within the Cochrane Collaboration, an international organization that evaluates medical practices through systematic reviews of research literature. Dr. Berman was the 2005 recipient of the Bravewell Leadership Award for his achievements in “transforming healthcare in America and ushering in a new practice of medicine.” Dr. Berman is also a practicing family physician and pain management specialist.
Dr. Carr is a Professor at Tufts University School of Medicine and directs its interprofessional program in Pain Research, Education and Policy, the only such program based in a department of public health and community medicine. A clinician and investigator, he has published in pain research, evidence-based medicine, and the social and political aspects of pain relief. He was Founding Editor of IASP’s Pain: Clinical Updates, co-founding editor for pain trials in the Cochrane review group on Pain, Palliative and Supportive Care, and serves on editorial boards of pain-related journals. Key publications include co-editing the first two DHHS clinical practice guidelines on pain; the first monograph on evidence, outcomes and quality of life in pain management; and the latest edition of the authoritative Cousins and Bridenbaugh text on neural blockade and pain medicine. Beyond his work with IASP and the US AHCPR and AHRQ, he has had advisory roles for the American Society of Anesthesiologists, the American Academy of Pain Medicine, the American Pain Society, the Interstitial Cystitis Association, the Phoenix Society for Burn Survivors the Joint Commission, NIH, FDA, and the American Chronic Pain Association. He holds 20 analgesia-related patents. His honors include ASRA’s Bonica Lecture, APS’s Fordyce, Distinguished Service, and Narcessian (Educational Excellence) Awards, AAPM’s Lippe and Founders’ Awards, and two citations from the Secretary of HHS.
Dr. Cohen obtained his medical degree at the Mount Sinai School of Medicine, completed an anesthesiology residency at Columbia University, and a pain management fellowship at Massachusetts General Hospital. Currently, he is Professor of Anesthesiology & Critical Care Medicine at the Johns Hopkins School of Medicine and Uniformed Services University of the Health Sciences. He is also Director of Medical Education and Quality Assurance for the Pain Management Division at Johns Hopkins, and Director of Pain Research at Walter Reed National Military Medical Center. Dr. Cohen has been very active in teaching and pain research in recent years, having published more than 200 peer-reviewed articles and book chapters in the past 10 years. Among his major contributions are the development of a new FDA-approved technique for treating sacroiliac joint pain (lateral branch radiofrequency denervation), inventing the intravenous ketamine test to help guide treatment in patients with chronic pain, and performing the first studies evaluating the local administration of cytokine inhibitors for pain. In addition to his academic work, Dr. Cohen is a Colonel in the Army Reserve, and Chief, Anesthesia & Operative Services at the 48h Combat Support Hospital. He also serves as the Reserve Liaison to the Pain Management Consultant to the U.S. Army Surgeon General. Dr. Cohen’s research was instrumental in the passage of the 2008 Military Pain Care Act, and he served as an inaugural member of the U.S. Army Medical Advisory Board.
Terrie Cowley is President and Co-founder of the TMJ Association, Milwaukee, Wis., a nonprofit organization established in 1989 to establish safe and effective means of diagnosis, treatment, and prevent temporomandibular joint disorders (TMJD). Ms. Cowley is also a founding member of the Chronic Pain Research Alliance - an umbrella advocacy organization for overlapping chronic pain disorders. Ms. Cowley has worked as a patient representative with several government agencies, including the Institute of Medicine, the NIH and the FDA on issues related to TMJD. Ms. Cowley studied government and history at Harvard University and holds a Bachelor's degree in Political Science from Millsaps College.
Dr. Margaret Faut Callahan is Interim Provost and Dean and Professor of Nursing at Marquette University. Dr. Callahan has served in various leadership capacities in state and national nursing and nurse anesthesia organizations. Dr. Callahan’s research interests are in the areas of pain management, palliative/end-of-life care, and health policy. She is a board member of the Clinical Translational Science Institute: Southeastern Wisconsin Regional Collaboration, member of the Board of Trustees of Rush University Medical Center, and the Board Quality Committee for Aurora Healthcare, Inc. She is an elected fellow in the American Academy of Nursing, the National Academies of Practice and the Institute of Medicine Chicago. Dr. Callahan serves as the Treasurer of the American Association of Colleges of Nursing. She also serves as an accreditation reviewer for the Council on Accreditation of Nurse Anesthesia Educational Programs and the Commission on Collegiate Nursing Education. She is a member of the American Nurses Association, American Association of Nurse Anesthetists and Sigma Theta Tau.
Dr. Scott M. Fishman is the Charles and Patricia Fullerton Endowed Chair of Pain Medicine, Professor of Anesthesiology and Pain Medicine, Chief of the Division of Pain Medicine, and Executive Vice Chair for the Department of Anesthesiology and Pain Medicine at the University of California, Davis School of Medicine. His medical degree is from the University of Massachusetts Medical School. He completed residency training in Internal Medicine (Greenwich/Yale University School of Medicine) and Psychiatry (Massachusetts General/Harvard Medical School) and Pain Medicine fellowship training through the Department of Anesthesia and Critical Care at Massachusetts General Hospital/Harvard Medical School. Dr. Fishman lectures on all aspects of pain control and advocates for education of all clinicians in pain and its management. He has authored, co-authored, and co-edited many books related to pain management. He has also authored many peer-reviewed articles in medical journals, book chapters, and other scholarly reviews, serves as senior editor of the journal Pain Medicine.
Dr. Keefe is a Professor in the Department of Psychiatry and Behavioral Sciences at Duke University Medical Center and a member of the Cancer Prevention, Detection, and Control Program of the Duke Comprehensive Cancer Center. Dr. Keefe is the Director of the Duke Pain Prevention and Treatment Research Program, an active clinical research program concerned with the behavioral assessment and treatment of patients having acute and persistent pain. Dr. Keefe played a key role in the development of clinical pain services and pain research programs at Duke Medical Center. For 20 years he directed the Pain Management Program and was a leader in the development of Duke Medical Center's multidisciplinary pain programs (both out-patient and in-patient.) Dr. Keefe has developed and refined a number of treatment protocols for persistent pain conditions (e.g. cancer, arthritis) including spouse and partner-assisted pain coping skills training interventions. He has conducted a number of randomized clinical trials testing the efficacy of these and other behavioral interventions. Dr. Keefe has served on numerous study sections and has chaired two NIH study sections (BMIO, PRDP). Dr. Keefe has published over 300 papers, as well as six (6) book chapters, and three (3) books on topics ranging from pain during mammography to the assessment of cancer pain at end-of-life. He currently serves as the Editor-in-Chief of the journal PAIN. In 2012 he was awarded the John D. Loeser award for excellence in clinical pain research by the International Association for the Study of Pain. Dr. Keefe serves as the liaison between the Professional Education and Training and Public Education and Communication working groups.
Dr. McCarberg is Founder of the Chronic Pain Management Program for Kaiser Permanente (retired) in San Diego, California. He is currently working with Neighborhood Healthcare in Escondido California. He is treasurer of the American Academy of Pain Medicine. He is president of the Western Pain Society and Adjunct Assistant Clinical Professor at the University of California at San Diego School Medicine. Dr. McCarberg is a member of the American Academy of Family Physicians, the American Academy of Pain Medicine, the American Pain Society, and the International Association for the Study of Pain. He is the recipient of several awards including the Shilling Compassionate Care Award, the Elizabeth Narcessian award for leader in the field of pain education from the American Pain Society and in 2008 was Ambassador of the Year for the National Pain Foundation. Member Appraisal of Physician Services at Kaiser Permanente rated Dr. McCarberg in the top 10% from 1998-2011. He has given more than 250 presentations on pain management issues and is the author or co-author of 115 articles, book chapters and books. He is board certified by the American College of Pain Medicine, the American Board of Family Practice and additionally certified in Geriatrics. Dr. McCarberg received his MD degree from Northwestern University Medical School in Chicago, Illinois. He completed a medical internship and a residency in family practice at Highland Hospital in Rochester, New York.
Dr. Schmidt is a surgeon-scientist who specializes in the clinical management of head and neck cancer. He leads a translational research program to investigate mechanisms of cancer pain and conduct clinical trials for new analgesics. Dr. Schmidt received his PhD at the University of California San Francisco (UCSF) where he also earned a DDS and MD and completed his residency in Oral and Maxillofacial Surgery. He completed a fellowship in head and neck oncology in Portland, Oregon. From 2002 until 2010 he was the Director of the Oral and Maxillofacial Oncology Fellowship, the Oral and Maxillofacial Surgery Residency Training Program and the Oral and Craniofacial Sciences PhD program at UCSF. He was Professor and Vice Chair of the Department of Oral and Maxillofacial Surgery. In July, 2010, Dr. Schmidt was named the Director of the Bluestone Center for Clinical Research at New York University. He was appointed as a Professor in both the Departments of Oral and Maxillofacial Surgery and Physiology and Neuroscience. His team includes clinicians, scientists, postdoctoral scholars, residents and fellows. Basic and clinical research scientists are structured collaboratively to characterize cancer pain phenotypes, elucidate mechanisms, and clinically evaluate new analgesics. He is the principal investigator of an NIH funded laboratory and NIH funded clinical studies. He maintains an active cancer practice.
Dr. Spellman is Executive Director of The Mayday Fund in New York City. Mayday is a small family foundation dedicated to alleviating the incidence, degree and consequence of human physical pain. The Fund was created in 1992. She is the second Executive Director and is responsible for overseeing the program of charitable giving on behalf of the Trustees of the Fund, as well as for the day-to-day administration of the Fund. The foundation is active in the United States and Canada. While at Mayday, Dr. Spellman has become familiar with various disciplines in medicine that address pain and its relief and represents the Fund at professional meetings. Among the goals of the Mayday Fund Trustees is to bring other funders to the table in support of pain programs. The Mayday Fund maintains an interest in the public policy debates surrounding the medical care of pain and supports the Mayday Pain and Society Fellowship, designed to help clinicians communicate more effectively. Dr. Spellman holds a PhD in Sociology and prior to joining Mayday taught at New York University.
Dr. Tauben is board certified in both Internal Medicine and Pain Medicine. He is currently interim Chief of the University of Washington Division of Pain Medicine, and continues as the Medical Director of the University of Washington Center for Pain Relief, Director of Medical Student Education in Pain Medicine at the UW, jointly appointed in the Departments of Medicine and Anesthesia & Pain Medicine. Dr. Tauben is medical director of UWTelePain, a tele-video-conferencing program intended to provide innovative pain education and consultative support to a five-state northwest regional primary care providers. He is principal investigator for the UW’s prestigious NIH Pain Consortium Center of Excellence for Pain Education, and is also leading curriculum development to extend the pain proficiency qualifications of primary care providers. He is a member of the American Pain Society and the International Association for the Study of Pain special interest study groups on Pain Education. He is a founding member of the State of Washington Agency Medical Directors panel of medical experts developing opioid prescription guidelines for the state, and a regular clinical and content expert for regulatory and legislative bodies involved in public policy regarding pain medicine practice and standards. He speaks as a clinical expert in medical management of chronic pain, especially as it applies to primary care practices. Dr. Tauben served as an expert for several US Centers for Disease Control clinical outreach programs advising primary care providers on how to prescribe opioids for chronic non-cancer pain. He is annually recognized by his peers as recipient of regional awards in care of pain patients, and brings decades of clinical experience of best practice medication management of acute and chronic pain.
Dr. Thomas began his career at the National Institutes of Health (NIH) in 1984, working in the intramural pain research program at the then National Institute on Dental Research where he studied opioids, pain and analgesia in monkeys and rats, using behavioral, pharmacological and electrophysiological approaches. Dr. Thomas joined the National Institute on Drug Abuse (NIDA) in 1995. He is currently a program official in the Division of Basic Neuroscience and Behavioral Research (DBNBR) where his program areas include pain and analgesia, opioids, virtual reality technologies and the abuse liability of analgesics. He is co-chair of NIDA Prescription Opioids and Pain workgroup, which fosters pain and opioid research and education. He is an original and current member of the NIH Pain Consortium, which promotes and pain research across the NIH, and he leads the NIH Pain Consortium’s Centers of Excellence in Pain Education program.
Dr. Willy is Associate Director for the Division of Risk Management in the Office of Medication Error Prevention and Risk Management in the Center for Drug Evaluation and Research (CDER) at FDA. Dr. Willy received her undergraduate degree in nursing from Case Western Reserve University. She received her Masters in Public Health and doctorate from the Johns Hopkins School of Public Health. She has worked for many years in the field of epidemiology and risk management. While at the FDA, Dr. Willy has worked in the area of drug safety as a team leader epidemiologist and she was the leader on several studies that looked at risk management-related issues. In 2006, Dr. Willy joined the risk management team, which later became the Division of Risk Management. She has served as a DRISK team leader, Deputy Director, and recently Associate Director. She participated in the implementation of the Food and Drug Administration Amendments Act of 2007 (FDAAA). For over a decade, Dr. Willy has worked on the regulatory aspects of the safe use of analgesic drug products. In particular, she participated in the Agency's efforts to address prescription opioid abuse. Most recently she served as a member of the working group that developed and reviewed the content of the Extended-Release/Long-Acting (ER/LA) opioid REMS. As part of that effort, she helped develop the FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics (“FDA Blueprint”). She has worked with various stakeholders, including academia, continuing education organizations, the pharmaceutical industry, and representatives from other federal agencies such as SAMHSA, CDC, and CMS. She continues to participate in the development of other REMS that include a focus on prescriber education, as well as on other prescription opioid abuse related matters.